Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Andrew Yaeh"'
Autor:
Jonathan Barasch, Angela M. Mills, Rosemary V. Sampogna, Andrew Yaeh, Katherine Xu, Vivette D. D'Agati, Krzysztof Kiryluk, Satoru Kudose, Jacob S. Stevens, Uddhav Neupane, Abraham Levitman, Sumit Mohan, Ning Shang, Alexa Corker
Publikováno v:
Kidney International Reports. 6:2979-2992
Introduction Loss of kidney function is a common feature of COVID-19 infection, but serum creatinine (SCr) is not a sensitive or specific marker of kidney injury. We tested whether molecular biomarkers of tubular injury measured at hospital admission
Autor:
Lena A. Kheir, Katherine Xu, Rebecca K. Breheney, John R. Burton, Britney A. Hatcher, Ariel E. Felman, Juliana N. Gamino, Hayley A. Giordano, Eddie F. Guerrero Herrera, Andrew Beenken, Aileen Gozali, Siddarth Arumugam, Jae I. Nha, Yaagnik D. Kosuri, Saul V. Lincoln, Anjali Gehani, Jacob S. Stevens, Osman R. Sayan, Jonathan Barasch, Tejashree S. Gopal, Erika K. Mitsui, Erin P. Geraghty, Miriam P. Callahan, Samuel J. Spaiser, Yuanji Li, Kristen L. King, Alexander T. Sayan, Alexa Corker, Andrew Yaeh, Samuel K. Sia, Sumit Mohan
Publikováno v:
Kidney International Reports
Introduction The identification of acute injury of the kidney relies on serum creatinine (SCr), a functional marker with poor temporal resolution as well as limited sensitivity and specificity for cellular injury. In contrast, urinary biomarkers of k
Autor:
Tony J. C. Wang, Andrew B. Lassman, Yasir H. Qureshi, Shumaila Saad, Andrew Yaeh, Michael B. Sisti, Steven R. Isaacson, Jeraldine Lesser, Cheng-Chia Wu, Sameer A. Sheth, Keith A. Cauley, Simon K. Cheng, Guy M. McKhann, Tavish Nanda, Jeffrey N. Bruce, Ashish Jani
Publikováno v:
Journal of Neuro-Oncology. 136:281-287
Prior studies of post-operative stereotactic radiosurgery (SRS) have not distinguished between Adjuvant SRS (ARS) versus Adjuvant SRS to residual/recurrent disease (ARD). In this study, we defined ARS and ARD and investigated local control (LC), over
Autor:
Tony J. C. Wang, Yandong Bian, C.H. Tai, Andrew Yaeh, Deborah R. Smith, M.E. Lapa, J.I.S. Andrews, Michael B. Sisti, Anurag Saraf, Tavish Nanda, Jeffrey N. Bruce, Cheng-Chia Wu, Guy M. McKhann, Simon K. Cheng
Publikováno v:
Journal of neuro-oncology. 143(1)
Non-small cell lung cancer (NSCLC) brain metastases are associated with substantial morbidity and mortality. During recent years, accompanying dramatic improvements in systemic disease control, NSCLC brain metastases have emerged as an increasingly r
Autor:
Yasir H. Qureshi, Tzlil Rozenblat, Shumaila Saad, Jeffrey N. Bruce, Andrew Yaeh, Guy M. McKhann, Ashish Jani, Andrew B. Lassman, Michael B. Sisti, Tavish Nanda, Steven R. Isaacson, Jeraldine Lesser, Tony J. C. Wang
Publikováno v:
Journal of Neuro-Oncology. 124:507-514
Renal cell carcinoma, sarcoma, and melanoma are considered to be "radioresistant" tumor histologies. Brain metastases (BM) from these tumors are considered unlikely to be controlled using the relatively low doses used in whole brain radiotherapy (WBR
Autor:
Yasir H. Qureshi, Tony J. C. Wang, Jeraldine Lesser, Jeffrey N. Bruce, Ashish Jani, Andrew B. Lassman, Tzlil Rozenblat, Guy M. McKhann, Shumaila Saad, Andrew Yaeh, Tavish Nanda, Michael B. Sisti, Wenzheng Feng, Steven R. Isaacson
Publikováno v:
Neurosurgery. 77:119-125
BACKGROUND The energy index (EI) is a measure of dose homogeneity within a target volume calculated by the integral dose divided by the product of prescription dose and tumor volume. OBJECTIVE To assess whether a higher EI is associated with greater
Autor:
Michael B. Sisti, Andrew B. Lassman, Tzlil Rozenblat, Yasir H. Qureshi, Shumaila Saad, Tony J. C. Wang, Andrew Yaeh, Jeffrey N. Bruce, Balazs Halmos, Tavish Nanda, Ashish Jani, Steven R. Isaacson, Jeraldine Lesser, Mark B. Stoopler, Guy M. McKhann, Simon K. Cheng
Publikováno v:
Neuro-Oncology. 17:1022-1028
BACKGROUND We investigated effects of genetic alterations in epidermal growth factor receptor (EGFR), anaplastic lymphoma kinase (ALK), and Kirsten rat sarcoma viral oncogene homolog (KRAS) on overall survival (OS) and local control after stereotacti
Autor:
Guy M. McKhann, Steven R. Isaacson, Eileen P. Connolly, Jeffery Bruce, Simon K. Cheng, Tzlil Rozenblat, Tavish Nanda, Ashish Jani, Shumaila Saad, Andrew Yaeh, Michael B. Sisti, Tony J. C. Wang, Jeraldine Lesser, Christopher S. Grubb, Yasir H. Qureshi, Cheng-Chia Wu
BACKGROUND: Recent studies have suggested a difference in outcome for breast cancer patients with brain metastases based on breast cancer subtype. These subtypes are defined as ER/PR+ and HER2- (luminal A), ER/PR+ and HER2+ (luminal B), ER/PR- and HE
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::76fdd10b44df10e7c2d97c0c9aca9c2b
https://europepmc.org/articles/PMC4638614/
https://europepmc.org/articles/PMC4638614/
Autor:
Michael B. Sisti, Ashish Jani, Eileen P. Connolly, Shumaila Saad, Andrew Yaeh, Tzlil Rozenblat, Simon K. Cheng, Cheng-Chia Wu, Guy M. McKhann, Jeffrey N. Bruce, Tavish Nanda, Sameer A. Sheth, Andrew B. Lassman, Jeraldine Lesser, Christopher S. Grubb, Steven R. Isaacson, Yasir H. Qureshi, Tony J. C. Wang
Publikováno v:
Journal of neuro-oncology. 127(1)
We investigated effects of breast cancer subtype on overall survival (OS), local and distant control, and time from initial diagnosis to brain metastases (BM). We also investigated advances in graded prognostic assessment (GPA) scores. A cohort of 72
Autor:
Yasir H. Qureshi, Jeffrey N. Bruce, Guy M. McKhann, Tzlil Rozenblat, Tavish Nanda, Shumaila Saad, Tony J. C. Wang, Andrew Yaeh, Ashish Jani, Andrew B. Lassman, Michael B. Sisti, Steven R. Isaacson
BACKGROUND: Renal cell carcinoma, sarcoma, and melanoma are considered to be “radioresistant” tumor histologies. Brain metastases (BM) from these tumors are unlikely to be controlled using the relatively low doses used in whole brain radiotherapy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f02e800b3b25625cc746118e81c97f5e
https://europepmc.org/articles/PMC4218545/
https://europepmc.org/articles/PMC4218545/